PQNT - ETF AI Analysis
Top Page
Pictet AI Enhanced International Equity ETF (PQNT)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the last few months, showing positive momentum.
Global Diversification
Holdings spread across many countries, including Japan, the UK, Europe, and others, help reduce reliance on any single market.
AI-Selected International Leaders
Several top positions, such as ASML and other financial and industrial names, have shown strong performance, suggesting the AI-driven stock selection has added value.
Negative Factors
Small Fund Size
With relatively low assets under management, the ETF may be less liquid and more vulnerable to large investor inflows or outflows.
Mixed Top Holding Performance
Some major positions, including AstraZeneca, Roche, and Sony, have been weak this year, which can drag on overall returns.
Moderate Expense Ratio
The fund’s fee is not especially high but is also not among the cheapest, which slightly reduces net returns over time.
PQNT vs. SPDR S&P 500 ETF (SPY)
AUM11.58M
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.86
IssuerPictet
Inception DateOct 15, 2025
Dividend Yield0.36%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume225
30 Day Avg. Volume598
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
26.83Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering294
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PQNT Summary
Pictet AI Enhanced International Equity ETF (PQNT) is an actively managed fund that uses artificial intelligence to pick stocks from developed markets outside North America. It doesn’t track a fixed index, but instead aims to find strong large- and mid-sized companies across many sectors, including financials, health care, and technology. Well-known holdings include ASML and Sony. Someone might invest in PQNT for diversified international stock exposure with an AI-driven stock selection approach that seeks growth. A key risk is that its share price can rise or fall with global stock markets, and its AI strategy may not always outperform.
How much will it cost me?The Pictet AI Enhanced International Equity ETF (PQNT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, using advanced AI technology to select investments rather than following a passive index. Active management typically involves more research and strategy, which increases costs.
What would affect this ETF?The Pictet AI Enhanced International Equity ETF (PQNT) could benefit from advancements in artificial intelligence and strong performance in developed markets outside North America, particularly in sectors like Financials, Industrials, and Technology, which make up a significant portion of its holdings. However, it may face challenges from global economic slowdowns, regulatory changes in international markets, or sector-specific risks, such as volatility in the Financial sector or slower growth in Technology. Additionally, currency fluctuations and geopolitical tensions in developed markets could negatively impact returns.
PQNT Top 10 Holdings
PQNT leans heavily into European and Japanese blue chips, with ASML acting as a key engine: its longer-term gains have been strong, even if recent trading has been a bit choppy. Health care is another pillar, where Novartis is steadily rising while AstraZeneca has been lagging and losing steam. Financials add some punch, with Spain’s BBVA climbing and helping performance. On the consumer side, British American Tobacco has been quietly rising, offsetting mixed tech exposure from names like Sony. Overall, it’s a diversified, developed-markets ex‑North America play with no single stock dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.35% | $387.78K | €547.84B | 141.04% | 76 Outperform | |
| AstraZeneca | 1.94% | $224.73K | $263.99B | 3.27% | 80 Outperform | |
| Roche Holding AG | 1.47% | $170.45K | $348.49B | 38.80% | 73 Outperform | |
| Novartis AG | 1.36% | $157.89K | CHF231.75B | 34.41% | 80 Outperform | |
| SAP SE | 1.30% | $150.58K | €184.10B | -31.77% | 66 Neutral | |
| British American Tobacco | 1.25% | $145.02K | £98.57B | 10.63% | 71 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.25% | $144.70K | €134.72B | 64.69% | 76 Outperform | |
| Mitsui & Co | 1.23% | $142.23K | ¥13.89T | 45.39% | 74 Outperform | |
| Sony | 1.23% | $142.13K | ¥22.44T | -10.18% | 73 Outperform | |
| ABN AMRO Group N.V. | 1.15% | $133.63K | €32.10B | 56.41% | 74 Outperform |
PQNT Technical Analysis
Positive
―
Price Trends
22.62
Positive
22.18
Positive
Market Momentum
0.11
Negative
59.92
Neutral
96.48
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PQNT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 22.73, equal to the 50-day MA of 22.62, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.11 indicates Negative momentum. The RSI at 59.92 is Neutral, neither overbought nor oversold. The STOCH value of 96.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PQNT.
PQNT Peer Comparison
Comparison Results
Performance Comparison
PQNT
Pictet AI Enhanced International Equity ETF
23.19
3.06
15.20%
QUIZ
Zacks Quality International ETF
―
―
―
AIVI
WisdomTree International AI Enhanced Value Fund
―
―
―
JIDE
JPMorgan International Dynamic ETF
―
―
―
ENHI
iShares Enhanced International Active ETF
―
―
―
TACN
T. Rowe Price Active Core International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents